Executives from AbbVie (NYSE:ABBV) outlined upcoming clinical milestones and development priorities across hidradenitis ...

Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 at Increased Risk for Severe RSV Over Two RSV Seasons ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Powerful mix of both trader and investor packs with timely expert advice. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

For all investors looking to unearth stocks that are poised to move. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and ...